PAVM Profile
PAVmed Inc., headquartered in New York, operates as a pioneering medical device company focused on developing and commercializing innovative solutions for unmet medical needs in the United States. Founded in 2014, the company is at the forefront of introducing advanced medical technologies designed to address critical healthcare challenges. Its product portfolio includes several key offerings and a robust pipeline of emerging technologies aimed at enhancing patient care and improving clinical outcomes.
Among PAVmed’s lead products is CarpX, a percutaneous device designed to treat carpal tunnel syndrome with minimal invasiveness. The company also offers EsoCheck, an esophageal cell collection device that facilitates early detection of esophageal adenocarcinoma and Barrett's Esophagus, a precancerous condition. Complementing this is EsoGuard, a next-generation sequencing DNA assay that aids in the early detection of esophageal cancer through bisulfite conversion technology. These products represent PAVmed’s commitment to advancing diagnostic and therapeutic options in critical areas of healthcare.
The company’s pipeline includes a diverse array of medical innovations. EsoCure, an esophageal ablation device, targets the treatment of dysplastic Barrett's Esophagus, aiming to prevent progression to cancer. PortIO is an implantable intraosseous vascular access device designed for rapid and reliable access to the bloodstream. The NextFlo technology represents a disposable infusion platform that enhances drug delivery, while the Veris cancer healthcare platform integrates remote monitoring and data analytics for personalized cancer care. Additionally, PAVmed is developing NextVent single-use ventilators, FlexMO medical circulatory support cannulas, and Veris cardiac monitors. The company’s offerings also include DisappEAR resorbable pediatric ear tubes and Solys, a noninvasive glucose monitoring device.
Formerly known as PAXmed Inc., PAVmed rebranded to its current name in April 2015 to better reflect its expanded focus on innovative medical solutions. The company continues to drive advancements in medical technology, with a strategic emphasis on addressing critical gaps in healthcare and improving patient outcomes. By leveraging cutting-edge technologies and a dynamic product pipeline, PAVmed aims to deliver impactful solutions that enhance the quality of care and meet the evolving needs of the medical community.
|
